Migraine clinical trials in Georgia
9 studies for Migraine are looking for participants at sites in Georgia.
Cities in Georgia
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Coastal Heritage Clinical Research, Hinesville
RecruitingPhase 1
Ages 6 to 11 · All sexes · Updated Sep 28, 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Clinical Trial Office, Augusta
- Augusta University, Augusta
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CenExel iResearch, LLC, Decatur
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CenExel iResearch, LLC, Decatur
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Responding With Evidence and Access for Childhood Headaches
- Clinical Integrative Research Center of Atlanta, Inc, Atlanta
Recruiting
Ages 10 to 17 · All sexes · Updated Sep 21, 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rare Disease Research /ID# 231046, Atlanta
- Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134, Atlanta
- Coastal Georgia Child Neurology /ID# 231409, Brunswick
- and 1 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302Study of EVO756 in Adults With Migraine
- Accel Research Site-Decatur-Alcanza, Decatur
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Sep 3, 2026 · NCT07616128A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Vista Clinical Research, Newnan
Recruiting
Ages 22 to 84 · All sexes · Updated Aug 28, 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- DelRicht Research, Atlanta
- Drug Studies America, Marietta
- Sleep Care Research Institute d/b/a Clinical Research Atlanta-Stockbridge, Stockbridge
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.